Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

1.

Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.

Jameson SS, Rymaszewska M, Hui AC, James P, Serrano-Pedraza I, Muller SD.

J Bone Joint Surg Am. 2012 Sep 5;94(17):1554-8.

PMID:
22832942
[PubMed - indexed for MEDLINE]
2.

Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.

Whang PG, Lieberman JR.

Am J Orthop (Belle Mead NJ). 2002 Sep;31(9 Suppl):31-6. Review.

PMID:
12349893
[PubMed - indexed for MEDLINE]
3.

Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.

Neumann I, Rada G, Claro JC, Carrasco-Labra A, Thorlund K, Akl EA, Bates SM, Guyatt GH.

Ann Intern Med. 2012 May 15;156(10):710-9. doi: 10.7326/0003-4819-156-10-201205150-00421. Epub 2012 Mar 12. Review.

PMID:
22412038
[PubMed - indexed for MEDLINE]
4.
5.

Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.

Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, Kluger J, Makanji S, Ashaye A, White CM.

Pharmacotherapy. 2012 Sep;32(9):799-808. doi: 10.1002/j.1875-9114.2012.01106.x. Epub 2012 Jun 28. Review.

PMID:
22744711
[PubMed - indexed for MEDLINE]
6.

Optimal duration of prophylaxis for venous thromboembolism following total hip arthroplasty and total knee arthroplasty.

Friedman RJ.

J Am Acad Orthop Surg. 2007 Mar;15(3):148-55. Review.

PMID:
17341671
[PubMed - indexed for MEDLINE]
7.

Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.

[No authors listed]

Prescrire Int. 2013 Apr;22(137):99-101, 103-4. Review.

PMID:
23662321
[PubMed - indexed for MEDLINE]
8.

Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.

Kwong LM.

Am J Manag Care. 2011 Feb;17(1 Suppl):S22-6. Review.

PMID:
21517652
[PubMed - indexed for MEDLINE]
Free Article
9.

[Benefit/risk ratio analysis from a possible anticoagulation of asymptomatic deep venous thrombosis in major orthopedic surgery].

Barrellier MT, Samama CM.

J Mal Vasc. 2013 May;38(3):178-84. doi: 10.1016/j.jmv.2013.01.002. Epub 2013 Feb 12. Review. French.

PMID:
23415379
[PubMed - indexed for MEDLINE]
10.

Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.

Welzel D, Hull R, Fareed J.

Int Angiol. 2011 Jun;30(3):199-211. Review.

PMID:
21617603
[PubMed - indexed for MEDLINE]
11.

Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?

Strebel N, Prins M, Agnelli G, B├╝ller HR.

Arch Intern Med. 2002 Jul 8;162(13):1451-6. Review.

PMID:
12090880
[PubMed - indexed for MEDLINE]
12.

Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.

Adam SS, McDuffie JR, Lachiewicz PF, Ortel TL, Williams JW Jr.

Ann Intern Med. 2013 Aug 20;159(4):275-84. doi: 10.7326/0003-4819-159-4-201308200-00008. Review.

PMID:
24026260
[PubMed - indexed for MEDLINE]
13.

Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.

Duggan ST.

Am J Cardiovasc Drugs. 2012 Feb 1;12(1):57-72. doi: 10.2165/11208470-000000000-00000. Review.

PMID:
22272729
[PubMed - indexed for MEDLINE]
14.

Clinical experience with ximelagatran in orthopaedic surgery.

Eriksson B.

Drugs. 2004;64 Suppl 1:27-35. Review.

PMID:
15586625
[PubMed - indexed for MEDLINE]
15.

Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures.

Handoll HH, Farrar MJ, McBirnie J, Tytherleigh-Strong G, Awal KA, Milne AA, Gillespie WJ.

Cochrane Database Syst Rev. 2000;(2):CD000305. Review. Update in: Cochrane Database Syst Rev. 2002;(4):CD000305.

PMID:
10796339
[PubMed - indexed for MEDLINE]
16.

Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.

Sharrock NE, Gonzalez Della Valle A, Go G, Lyman S, Salvati EA.

Clin Orthop Relat Res. 2008 Mar;466(3):714-21. doi: 10.1007/s11999-007-0092-4. Epub 2008 Feb 10. Review.

PMID:
18264861
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.

Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE.

Ann Intern Med. 2001 Nov 20;135(10):858-69. Review.

PMID:
11712876
[PubMed - indexed for MEDLINE]
18.

Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials.

Alhazzani W, Lim W, Jaeschke RZ, Murad MH, Cade J, Cook DJ.

Crit Care Med. 2013 Sep;41(9):2088-98. doi: 10.1097/CCM.0b013e31828cf104. Review.

PMID:
23782973
[PubMed - indexed for MEDLINE]
19.

What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?

Kamphuisen PW, Agnelli G.

Thromb Res. 2007;119(3):265-74. Epub 2006 May 3. Review.

PMID:
16674999
[PubMed - indexed for MEDLINE]
20.

Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.

Stevenson M, Scope A, Holmes M, Rees A, Kaltenthaler E.

Health Technol Assess. 2009 Oct;13 Suppl 3:43-8. doi: 10.3310/hta13suppl3/07. Review.

PMID:
19846028
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk